These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 20373253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved therapeutic entities derived from known generics as an unexplored source of innovative drug products.
    Stegemann S, Klebovich I, Antal I, Blume HH, Magyar K, Németh G, Paál TL, Stumptner W, Thaler G, Van de Putte A, Shah VP.
    Eur J Pharm Sci; 2011 Nov 20; 44(4):447-54. PubMed ID: 21968337
    [Abstract] [Full Text] [Related]

  • 3. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV, Kirkegaard H, Kruse E, Kruse PR.
    Theriaca; 2014 Nov 20; (42):31-62. PubMed ID: 25816561
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Generics: keep a balanced view.
    Prescrire Int; 2014 Feb 20; 23(146):52-5. PubMed ID: 24669392
    [Abstract] [Full Text] [Related]

  • 8. The interaction between intellectual property and drug regulatory systems: global perspectives.
    Madden EA.
    IDrugs; 2007 Feb 20; 10(2):116-20. PubMed ID: 17285464
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A vision of the pharmaceutical industry.
    Muñio S.
    Methods Find Exp Clin Pharmacol; 1998 Feb 20; 20 Suppl A():5-9. PubMed ID: 9800720
    [Abstract] [Full Text] [Related]

  • 11. The changing environment for technological innovation in health care.
    Goodman CS, Gelijns AC.
    Baxter Health Policy Rev; 1996 Feb 20; 2():267-315. PubMed ID: 11066263
    [Abstract] [Full Text] [Related]

  • 12. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI, Revel L, Rosa E, Cruces E.
    Drug News Perspect; 2009 Feb 20; 22(1):39-51. PubMed ID: 19209298
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Secondary patents in the pharmaceutical industry: missing the wood for the trees?
    Kiran S, Kulkarni M.
    Expert Opin Ther Pat; 2018 Mar 20; 28(3):241-250. PubMed ID: 29298119
    [Abstract] [Full Text] [Related]

  • 15. How drug life-cycle management patent strategies may impact formulary management.
    Berger J, Dunn JD, Johnson MM, Karst KR, Shear WC.
    Am J Manag Care; 2016 Oct 20; 22(16 Suppl):S487-S495. PubMed ID: 28719222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Current trends in the pharmaceutical industry--a case study approach.
    Rusu A, Kuokkanen K, Heier A.
    Eur J Pharm Sci; 2011 Oct 09; 44(3):437-40. PubMed ID: 21782941
    [Abstract] [Full Text] [Related]

  • 19. The economics of pediatric formulation development for off-patent drugs.
    Milne CP, Bruss JB.
    Clin Ther; 2008 Nov 09; 30(11):2133-45. PubMed ID: 19108801
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.